Evidence map›Paper›PMID 41408591›Full record

ArticleBMC plant biology2025

Discovery of globally rare CYP51 mutations associated with azole resistance in Iranian Zymoseptoria tritici isolates.

Azar Esfehani, Debabrata Dutta, Guido Puccetti, Pablo Antonio Chong Aguirre, Ehssan Torabi, Naser Mohammadi, Daniel Croll, Angela Feechan, Amir Mirzadi Gohari

Abstract read
In one paragraph

Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Azar EsfehaniDepartment of Plant Protection, Faculty of Agriculture, University College of Agriculture & Natural Resources, University of Tehran, Karaj, Iran.
Debabrata DuttaInstitute for Life and Earth Sciences, School of Energy, Geoscience, Infrastructure and Society, Heriot-Watt University, Edinburgh, UK.
Guido PuccettiLaboratory of Evolutionary Genetics, Institute of Biology, University of Neuchâtel, Neuchâtel, CH-2000, Switzerland.
Pablo Antonio Chong AguirreESPOL Polytechnic University, ESPOL, Centro de Investigaciones Biotecnológicas del Ecuador, Laboratorio de Biología Molecular, Campus Gustavo Galindo, Km 30.5 Vía Perimetral, Guayaquil, 090902, Ecuador.
Ehssan TorabiDepartment of Plant Protection, Faculty of Agriculture, University College of Agriculture & Natural Resources, University of Tehran, Karaj, Iran.
Naser MohammadiDryland Agricultural Research Institute, Agricultural Research, Education and Extension Organization (ARREO), Maragheh, Iran.
Daniel CrollLaboratory of Evolutionary Genetics, Institute of Biology, University of Neuchâtel, Neuchâtel, CH-2000, Switzerland.
Angela FeechanInstitute for Life and Earth Sciences, School of Energy, Geoscience, Infrastructure and Society, Heriot-Watt University, Edinburgh, UK.
Amir Mirzadi GohariDepartment of Plant Protection, Faculty of Agriculture, University College of Agriculture & Natural Resources, University of Tehran, Karaj, Iran. mirzadighohari@ut.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeptoria tritici blotch, caused by Zymoseptoria tritici, is a major wheat disease worldwide. Demethylation inhibitor (DMI) fungicides, which target the sterol 14α-demethylase enzyme encoded by the CYP51 gene, remain central to disease control. In Iran, propiconazole is extensively applied, raising concerns about the evolution of resistance. This study investigated potential CYP51-mediated resistance mechanisms in Iranian Z. tritici populations.

resultsTwenty-eight isolates collected from six major wheat-producing provinces were assessed for propiconazole sensitivity using a microdilution assay and were classified as sensitive, tolerant, or resistant based on IC₅₀ values. Sequencing of the CYP51 coding region in representative isolates revealed several amino acid substitutions. Two novel mutations (G450R and G516D) were identified, together with rare variants previously reported at low global frequencies (E454K and L4V) and well-established resistance-associated changes such as Y461S and ΔY459/G460. These mutations defined seven haplotypes with variable resistance phenotypes. To validate these findings, we also performed whole-genome sequencing (WGS) on representative Iranian isolates. The WGS results were fully consistent with targeted sequencing, confirming the robustness of CYP51 mutation detection. Gene expression analysis showed inducible CYP51 upregulation in the most resistant isolate. Structural modelling using both homology-based and AlphaFold2 predictions indicated that the novel substitutions may alter surface electrostatics or cavity properties of the enzyme, potentially affecting fungicide binding.

conclusionsThis study documents the emergence of novel resistance-associated mutations in Iranian Z. tritici populations, expanding the spectrum of known CYP51 variants. The findings highlight the interplay between coding mutations, regulatory changes, and structural flexibility in shaping fungicide resistance. An integrated approach combining phenotypic assays, sequencing, expression analysis, and structural modelling provides a robust framework for monitoring resistance and informing sustainable fungicide use in wheat disease management.

Indexed as

AscomycotaAzolesDrug Resistance, FungalFungal ProteinsFungicides, IndustrialSterol 14-DemethylaseTriticumIranMutationPlant DiseasesTriazolesAzolesFungal ProteinsFungicides, IndustrialpropiconazoleSterol 14-DemethylaseTriazolesAzole resistanceCYP51 mutationsFungicide resistanceHaplotypesPropiconazoleStructural modellingZymoseptoria tritici

Identifiers

PMID41408591
PMCPMC12822247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.